Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients.

Xiaobo BoJie WangTao SuoXiaoling NiHan LiuSheng ShenMin LiYueqi WangHoubao LiuJiejie Xu

Published in: BMC cancer (2018)

TIMs infiltration is an independent favorable prognostic factor in GBC and EBDC patients, which could better stratify patients with different prognosis and predict benefit from gemcitabine-based ACT.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
early stage
squamous cell carcinoma